PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Quotient Bioresearch to Highlight Integrated Early Stage Drug Development Platforms at FIP Pharmaceutical Sciences World Congress 2010 - Quotient Bioresearch, will be highlighting its unique Translational Pharmaceutics and Synthesis-to-Clinic platforms at FIP Pharmaceutical Sciences World Congress 2010 in association with AAPS Annual Meeting & Exposition, New Orleans, 14-18 November, on bo
Quotient Bioresearch to Highlight Integrated Early Stage Drug Development Platforms at FIP Pharmaceutical Sciences World Congress 2010

 

NewswireToday - /newswire/ - Cambridgeshire, United Kingdom, 2010/10/13 - Quotient Bioresearch, will be highlighting its unique Translational Pharmaceutics and Synthesis-to-Clinic platforms at FIP Pharmaceutical Sciences World Congress 2010 in association with AAPS Annual Meeting & Exposition, New Orleans, 14-18 November, on bo.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Quotient Bioresearch, a leading provider of early and specialist drug development services, will be highlighting its unique Translational Pharmaceutics and Synthesis-to-Clinic platforms at FIP Pharmaceutical Sciences World Congress 2010 in association with AAPS Annual Meeting & Exposition, New Orleans, 14-18 November, on booth #3019.

The Translational Pharmaceutics platform has redefined early development processes by integrating the development and provision of drug products (formulation development, pharmaceutical analysis and GMP manufacturing) with clinical testing. The transition of molecules from discovery to the First-in-Human programme can be streamlined and accelerated. The RapidFACT service, part of the Translational Pharmaceutics platform, is used to optimise drug products prior to full development, reducing timelines and associated costs by more than fifty percent.

Quotient's Synthesis-to-Clinic platform is designed to support its 14C enabled drug development services, including clinical microdose, microtracer and drug metabolism studies. Incorporating a full spectrum of radiosynthesis, preclinical and clinical capabilities, it provides a flexible and integrated process, delivering significant efficiencies to customers. Innovations in the process of 14C radiolabelling ensure that all requirements in a development project can be satisfied through a single synthesis campaign.

Mark Egerton, Quotient Bioresearch commented: "At Quotient we have a unique approach to providing drug development support, offering integrated, flexible platforms for all stages of early drug development. Our capabilities underpinning these platforms include custom radiosynthesis, pharmaceutical sciences, metabolism support, bioanalysis and early clinical development. We understand the challenges of pharmaceutical R&D and use our scientific expertise to design bespoke programmes, answering the key questions in our customers' R&D projects."

Quotient will also be presenting five posters covering a range of topics
including:

. Addressing the challenges of poor solubility: Rapid development and clinical evaluation of a lipid based formulation to enhance oral bioavailability of amuvatinib (MP-470, co-authored with Supergen)

. Quality Standards for 14C API for use in human clinical studies

. Determination of AZP-502, an 8 aa synthetic peptide for treatment of type 2 diabetes mellitus and two of its metabolites in rat and dog plasma using LC-MS/MS

. Elucidation of the relative bioavailability of a drug candidate from different regions of the human gastrointestinal tract (co-authored with Merck)

. Applications of Therapeutic Range Exploratory Approaches from ICH M3(R2) (co-authored with Merck)

To learn more about Quotient's service offering, please visit booth #3019 at FIP Pharmaceutical Sciences World Congress 2010 in association with AAPS Annual Meeting & Exposition. Alternatively please call +44 (0)1638 720 500, or email info[.]quotientbioresearch.com.

About Quotient Bioresearch

Quotient (quotientbioresearch.com) is a leading provider of early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide. The company offers a unique range of drug development services through its three key focus areas - Chemistry & Metabolism, Bioanalytical Sciences and Clinical Sciences. Quotient has grown rapidly in the past three years, through a combination of both acquisition-led and organic growth. Quotient Bioresearch is part of Quotient Bioresearch Group, which comprises Quotient Bioresearch and HFL Sport Science.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: The Scott Partnership

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Quotient Bioresearch to Highlight Integrated Early Stage Drug Development Platforms at FIP Pharmaceutical Sciences World Congress 2010

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Scottpr.com 
+44 1477 539539 quotient[.]scottpr.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From The Scott Partnership / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Sparta Systems Broadens Partnership with TrackWise Implementation Specialist Equality Systems
Thales Launches the Pixium Portable 3543 DR Wifi Enabled Flat Panel Detector
GE Healthcare Showcases Industry-first Technologies and Digital Solutions, Focused on Improving Outcomes, At RSNA 2016
Agfa and LCsys Team Up to Launch ABSOLUT-ID, Their Turnkey Integrated Solution for the Production of High Security ID Cards
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference
AccuVein to Exhibit Leading Vein Visualization Technology at American Society for Dermatologic Surgery Annual Meeting
US Biomedical Textiles Transform Implant Device Technology by Aligning to Changes in Patient Preference Finds Frost & Sullivan
Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)